Get your copy now!

A paradigm shift in flexible biopharmaceutical production sites and process designs has been recognized in multiple scientific publications and conferences. This paradigm shift requires capacity utilization and process flexibility. The large area, product dedicated brick and mortar facilities can no longer meet these requirements which ushers in the need for more versatile and agile facilities in different regions.

White Paper:  Flexible Production Platforms for Biopharmaceutical Manufacturing

With new demands by the industry comes new facility design offerings, which claim to be “flexible facilities,” “modular facilities” or facilities that are capable of “manufacturing on demand.”

This paper addresses:

  • Description of the various facility models currently being used in biopharmaceutical manufacturing

  • Difference between modular and flexible facilities

  • Facility options decision making matrix

  • Exploration of the benefits of the autonomous pod


This white paper is sponsored by G-Con.